These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 36219578)

  • 1. Comparative analysis of sensitivity and specificity of computer-aided cognitive test in screening mild cognitive impairment patients and test of reliability and validity.
    Ma J; Li R; Zhang W; Huang L; Wang X; He Y; Jin S; Liu M; Wang J; Xiao W; Xie Z; Lu Z; Nie Z; Li Y
    Appl Neuropsychol Adult; 2024; 31(6):1391-1397. PubMed ID: 36219578
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation of the Spanish-language version of the Montreal Cognitive Assessment test in adults older than 60 years.
    Delgado C; Araneda A; Behrens MI
    Neurologia (Engl Ed); 2019; 34(6):376-385. PubMed ID: 28364958
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validity and Reliability of the Spanish Version of the Montreal Cognitive Assessment (MoCA) for the Detection of Cognitive Impairment in Mexico.
    Aguilar-Navarro SG; Mimenza-Alvarado AJ; Palacios-García AA; Samudio-Cruz A; Gutiérrez-Gutiérrez LA; Ávila-Funes JA
    Rev Colomb Psiquiatr (Engl Ed); 2018; 47(4):237-243. PubMed ID: 30286846
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Accuracy and Psychometric Properties of the Brazilian Version of the Montreal Cognitive Assessment as a Brief Screening Tool for Mild Cognitive Impairment and Alzheimer's Disease in the Initial Stages in the Elderly.
    Pinto TCC; Machado L; Costa MLG; Santos MSP; Bulgacov TM; Rolim APP; Silva GA; Rodrigues-Júnior AL; Sougey EB; Ximenes RCC
    Dement Geriatr Cogn Disord; 2019; 47(4-6):366-374. PubMed ID: 31466064
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validity and Reliability of the Turkish Version of Mild Behavioral Impairment Checklist in Patients With Cognitive Impairment.
    Pektas İC; Budak C; Pektas K; Sahin Cam C; Tasdelen R; Ilgin C; Ergun S
    J Geriatr Psychiatry Neurol; 2024 Sep; 37(5):387-394. PubMed ID: 38378176
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative study of two Chinese versions of Montreal Cognitive Assessment for Screening of Mild Cognitive Impairment.
    Huang YY; Qian SX; Guan QB; Chen KL; Zhao QH; Lu JH; Guo QH
    Appl Neuropsychol Adult; 2021; 28(1):88-93. PubMed ID: 31014115
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validation of the Spanish-language version of the Montreal Cognitive Assessment as a screening test for cognitive impairment in multiple sclerosis.
    Gomez-Moreno SM; Cuadrado ML; Cruz-Orduña I; Martínez-Acebes EM; Gordo-Mañas R; Fernández-Pérez C; García-Ramos R
    Neurologia (Engl Ed); 2022; 37(9):726-734. PubMed ID: 34836843
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preliminary study of the reliability and validity of the Johns Hopkins Adapted Cognitive Exam (Chinese version) in neurological intensive care unit patients.
    Wu YH; Yao QJ; Zhang Y; Wang Y; Wang H; Zhang Y
    Brain Inj; 2019; 33(2):137-142. PubMed ID: 30395730
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic accuracy, reliability, and construct validity of the German quick mild cognitive impairment screen.
    Manser P; de Bruin ED
    BMC Geriatr; 2024 Jul; 24(1):613. PubMed ID: 39026157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validation of the Turkish Version of the Montreal Cognitive Assessment Scale (MoCA-TR) in patients with Parkinson's disease.
    Ozdilek B; Kenangil G
    Clin Neuropsychol; 2014; 28(2):333-43. PubMed ID: 24528299
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validation of the Chinese version of Addenbrooke's cognitive examination-revised for screening mild Alzheimer's disease and mild cognitive impairment.
    Fang R; Wang G; Huang Y; Zhuang JP; Tang HD; Wang Y; Deng YL; Xu W; Chen SD; Ren RJ
    Dement Geriatr Cogn Disord; 2014; 37(3-4):223-31. PubMed ID: 24193223
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validation of the Chinese version of Addenbrooke's cognitive examination III for detecting mild cognitive impairment.
    Pan FF; Wang Y; Huang L; Huang Y; Guo QH
    Aging Ment Health; 2022 Feb; 26(2):384-391. PubMed ID: 33533261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validity and reliability of the Persian version of the Montreal Cognitive Assessment (MoCA-P) scale among subjects with Parkinson's disease.
    Badrkhahan SZ; Sikaroodi H; Sharifi F; Kouti L; Noroozian M
    Appl Neuropsychol Adult; 2020; 27(5):431-439. PubMed ID: 30821505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic utility of the Addenbrooke's Cognitive Examination - III (ACE-III), Mini-ACE, Mini-Mental State Examination, Montreal Cognitive Assessment, and Hasegawa Dementia Scale-Revised for detecting mild cognitive impairment and dementia.
    Senda M; Terada S; Takenoshita S; Hayashi S; Yabe M; Imai N; Horiuchi M; Yamada N
    Psychogeriatrics; 2020 Mar; 20(2):156-162. PubMed ID: 31448862
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reliability and Validity of the Beijing Version of the Montreal Cognitive Assessment in the Evaluation of Cognitive Function of Adult Patients with OSAHS.
    Chen X; Zhang R; Xiao Y; Dong J; Niu X; Kong W
    PLoS One; 2015; 10(7):e0132361. PubMed ID: 26208289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cognitive Screening Tests in Huntington Gene Mutation Carriers: Examining the Validity of the Mini-Mental State Examination and the Montreal Cognitive Assessment.
    Ringkøbing SP; Larsen IU; Jørgensen K; Vinther-Jensen T; Vogel A
    J Huntingtons Dis; 2020; 9(1):59-68. PubMed ID: 31658065
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new device-aided cognitive function test, User eXperience-Trail Making Test (UX-TMT), sensitively detects neuropsychological performance in patients with dementia and Parkinson's disease.
    Kokubo N; Yokoi Y; Saitoh Y; Murata M; Maruo K; Takebayashi Y; Shinmei I; Yoshimoto S; Horikoshi M
    BMC Psychiatry; 2018 Jul; 18(1):220. PubMed ID: 29976167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Criterion and convergent validity of the Montreal cognitive assessment with screening and standardized neuropsychological testing.
    Lam B; Middleton LE; Masellis M; Stuss DT; Harry RD; Kiss A; Black SE
    J Am Geriatr Soc; 2013 Dec; 61(12):2181-2185. PubMed ID: 24320735
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Reliable Tool for Assessing MCI and Dementia: Validation Study of DemTect for Turkish Population.
    Aycicek GS; Çalıskan H; Ozsurekci C; Unsal P; Kessler J; Kalbe E; Esme M; Dogrul RT; Balcı C; Seven U; Karabulut E; Halil M; Cankurtaran M; Yavuz BB
    Am J Alzheimers Dis Other Demen; 2020; 35():1533317520949805. PubMed ID: 32964729
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validation of the Chinese Version of Montreal Cognitive Assessment Basic for Screening Mild Cognitive Impairment.
    Chen KL; Xu Y; Chu AQ; Ding D; Liang XN; Nasreddine ZS; Dong Q; Hong Z; Zhao QH; Guo QH
    J Am Geriatr Soc; 2016 Dec; 64(12):e285-e290. PubMed ID: 27996103
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.